Resumo

DIAZ-COTO, José et al. Pre-assessment of pharmacological immunosuppression in Rheumatology. Acta méd. costarric [online]. 2017, vol.59, n.4, pp.153-157. ISSN 0001-6002.

In the last 15 years therapies and therapeutic schemes have been developed to induce remission to the vast majority of rheumatologic diseases. The clinical improvement achieved is at the cost of a more aggressive and specific immunosuppression, which leads to an increase in the risk of infections. The main cause of death of autoimmune diseases in the first 5 years of evolution is infection secondary to immunosuppression. The objective of the present study was to develop a consensus document with the aim of reducing this risk of infection, based on the best available medical evidence, using the resources available in our hospital to reduce the morbidity and mortality of patients receiving these therapies. Having a consensus document will allow us to minimize side effects and improve therapeutic action with greater opportunities for referral and better utilization of institutional resources.

Palavras-chave : Biological agents; immunosuppression; protocols; rheumatic disease; treatment; prophylaxis.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )